Antimicrobial Resistance & Infection Control

Table 1 Antibiotic susceptibility pattern of Enterobacteriaceae containing ESBL related genes

From: Assessment of extended-spectrum β-lactamases and integrons among Enterobacteriaceae in device-associated infections: multicenter study in north of Iran

		Klebsiella pneumoniae				Enterobacter .spp				E.coli
		N = 24				N = 5				N = 6
		Positive ESBL related genes
		SHV	CTX	VEB	GES	SHV	CTX	VEB	GES	SHV	CTX	VEB	GES
		N = 22	N = 14	N = 4	N = 4	N = 5	N = 2	N = 3	N = 1	N = 6	N = 1	N = 1	N = 1
Amikacin	R	50	50	25	25	60	100	33	0	66.6	100	100	100
	I	27.2	28.5	50	25	40	0	66	100	16.6	0	0	0
	S	22.7	21.5	25	50	0	0	0	0	16.6	0	0	0
Ciprofloxacin	R	40.9	50	0	25	0	0	0	0	33.3	0	0	100
	I	31.8	28.5	50	50	0	0	0	0	-	-	-	-
	S	27.2	21.5	50	25	100	100	100	100	66.6	100	100	0
Imipenem	R	36.3	50	25	50	0	0	0	0	16.6	0	0	0
	I	27.2	28.5	25	25	20	50	33	100	16.6	0	0	100
	S	36.3	21.5	50	25	80	50	66	0	66.6	100	100	0
Gentamicin	R	81.8	85.7	50	100	80	100	33	0	83.33	100	100	100
	I	4.54	0	0	0	20	0	33	100	16.6	0	0	0
	S	13.63	14.2	50	0	0	0	33	0	-	-	-	-
Ceftazidime	R	72.7	57.14	75	50	60	50	100	100	50	100	100	0
	I	27.2	35.7	25	25	40	50	0	0	33.3	0	0	100
	S	13.63	7.1	0	25	0	0	0	0	16.6	0	0	0
Tobramycin	R	59	64.28	50	25	60	100	33	0	33.3	0	0	100
	I	31.8	28.57	50	50	0	0	0	0	16.6	0	100	0
	S	9.1	7.1	0	25	40	0	66	100	50	100	0	0
Piperacillin-Tazobactam	R	63.6	64.28	50	75	60	0	33	100	16.6	0	0	0
	I	31.8	28.57	25	25	0	50	66	0	66.6	100	100	100
	S	4.54	7.1	25	0	40	50	0	0	16.6	0	0	0
Cefepime	R	72.7	85.71	25	100	60	100	66	100	33.3	0	100	0
	I	9.1	7.1	25	0	20	0	0	0	16.6	0	0	100
	S	18.18	7.1	50	0	20	0	33	0	50	100	0	0
Colistin	R	72.7	71.42	50	25	40	100	33	0	33.3	0	0	100
	I	27.2	14.2	25	25	20	0	0	0	16.6	100	0	0
	S	13.63	14.2	25	50	40	0	66	100	50	0	100	0
Co-trimoxazole	R	81.8	85.71	75	75	80	100	66	0	33.3	0	100	100
	I	-	-	-	-	0	0	0	0	-	-	-	-
	S	18.2	14.2	25	25	20	0	33	100	66.6	100	0	0

R resistant, I intermediate, S sensitive

Back to article page

ISSN: 2047-2994

Contact us

General enquiries: journalsubmissions@springernature.com